SlideShare a Scribd company logo
1 of 20
Download to read offline
Preven&ng	
  Prescrip&on	
  Drug	
  Abuse	
  



                                 April	
  10-­‐12,	
  2012	
  
                       Walt	
  Disney	
  World	
  Swan	
  Resort	
  



                         R.	
  Gil	
  Kerlikowske,	
  
                                  Director	
  
     White	
  House	
  Office	
  of	
  Na;onal	
  Drug	
  Control	
  Policy	
  
Na;onal	
  Drug	
  Control	
  Strategy	
  
•  Science-­‐based,	
  public	
  health	
  approach	
  to	
  drug	
  policy	
  
•  Coordinated	
  federal	
  effort	
  on	
  115	
  ac&on	
  items	
  	
  
    –  Special	
  emphasis	
  on	
  ac&ve	
  duty,	
  veterans,	
  and	
  military	
  families;	
  women	
  and	
  girls;	
  
       individuals	
  in	
  the	
  criminal	
  jus&ce	
  system;	
  and	
  college	
  students	
  
•  Signature	
  ini&a&ves	
  
    –  Prescrip&on	
  Drug	
  Abuse	
  
    –  Preven&on	
  
    –  Drugged	
  Driving	
  
Pain	
  Reliever	
  Prescrip;ons:	
  2000-­‐2009	
  




     ER	
  –	
  Extended	
  Release,	
  LA	
  –	
  Long-­‐Ac&ng,	
  IR	
  –	
  Immediate	
  Release	
  
     Source:	
  SDI,	
  Vector	
  One:	
  Na;onal.	
  	
  Extracted	
  June	
  2010.	
  
2011 Monitoring the Future Study	
  
      Prevalence of Past Year Drug Use Among 12th graders	
  

            Drug          Prev.              Drug                   Prev.
 Alcohol                  63.5    OxyContin*                         4.9
 Marijuana/Hashish        36.4    Sedatives*                         4.3
 Synthetic Marijuana      11.4    Hall other than LSD                4.3
 Amphetamines*             8.2    Inhalants                          3.2
 Vicodin*                  8.1    Cocaine (any form)                 2.9
 Adderall*                 6.5    LSD                                2.7
 Salvia                    5.9    Ritalin*                           2.6
 Tranquilizers*            5.6    Ketamine                           1.7
 Cough Medicine*           5.3    Provigil                           1.5
 MDMA (Ecstasy)            5.3    GHB                                1.4
 Hallucinogens             5.2    Methamphetamine                    1.4
* Nonmedical use                              Categories not mutually exclusive
Prescrip;ons	
  Dispensed	
  for	
  select	
  opioids	
  in	
  U.S.	
  
                                        Outpa;ent	
  Retail	
  Pharmacies,	
  2000-­‐2009	
  
                                    140,000,000	
  


                                    120,000,000	
  


                                    100,000,000	
  
 Number	
  of	
  Prescrip;ons	
  




                                     80,000,000	
  


                                     60,000,000	
  


                                     40,000,000	
  


                                     20,000,000	
  


                                                0	
  
                                                            2000	
     2001	
       2002	
        2003	
        2004	
       2005	
         2006	
     2007	
     2008	
         2009	
  

                                                        Hydrocodone	
             Oxyocodne	
                methadone	
                buprenorphine	
           tramadol	
  
Source:	
  SDI,	
  Vector	
  One:	
  Na;onal.	
  	
  Extracted	
  June	
  2010.	
  
Uninten&onal	
  Drug	
  Overdose	
  Deaths	
  
                                           United	
  States,	
  1970–2007  	
  

                                                  27,658	
  uninten&onal	
  drug	
  overdose	
  deaths	
  




                                                                       Cocaine	
  
                                     Heroin	
  




                                                                        Year	
  


Na;onal	
  Vital	
  Sta;s;cs	
  System,	
  hZp://wonder.cdc.gov	
  
Emergency	
  Department	
  Visits	
  
Persons	
  Classified	
  with	
  Substance	
  Abuse/
    Dependence	
  on	
  Psychotherapeu;cs	
  
2,500	
  


2,000	
  


1,500	
  


1,000	
  


  500	
  


        0	
  
                     2002	
              2003	
               2004	
              2005	
               2006	
              2007	
              2008	
         2009	
     2010*	
  

 Results	
  from	
  the	
  2010	
  Na2onal	
  Survey	
  on	
  Drug	
  Use	
  and	
  Health	
  (NSDUH):	
  Na2onal	
  Findings,	
  SAMHSA	
  (2011).	
  	
  
 hXp://www.oas.samhsa.gov/nsduhLatest.htm.	
  
 *Number	
  in	
  2010	
  is	
  sta;s;cally	
  significantly	
  higher	
  than	
  in	
  2005.	
  
Drug-­‐Induced	
  Deaths	
  vs.	
  Other	
  Injury	
  Deaths,	
  1999–
                                   2009	
  
                               50,000
                               45,000
            NUMBER OF DEATHS


                               40,000
                               35,000
                               30,000
                               25,000
                               20,000
                               15,000
                               10,000
                                 5,000
                                            0            1999	
           2000	
            2001	
           2002	
           2003	
            2004	
           2005	
           2006	
            2007	
           2008	
          2009	
  
      Injury	
  by	
  firearms	
                        28,874	
          28,663	
         29,573	
          30,242	
         30,136	
         29,569	
         30,694	
          30,896	
         31,224	
         31,593	
         31,347	
  
      Drug-­‐induced	
                                  19,128	
         19,720	
         21,705	
          26,040	
         28,723	
         30,711	
          33,541	
         38,396	
         38,371	
         38,649	
         39,147	
  
      Homicide	
                                        16,889	
         16,765	
         20,308	
          17,638	
         17,732	
         17,357	
         18,124	
          18,573	
         18,361	
         17,826	
         16,799	
  
      Suicide	
                                         29,199	
         29,350	
         30,622	
          31,655	
         31,484	
         32,439	
         32,637	
          33,300	
         34,598	
         36,035	
         36,909	
  
      Motor	
  vehicle	
  accidents	
   42,401	
                         43,356	
         43,788	
          45,380	
         44,757	
         44,933	
          45,343	
         45,316	
         43,495	
         39,790	
         36,216	
  

Causes	
  of	
  death	
  aZributable	
  to	
  drugs	
  include	
  accidental	
  or	
  inten;onal	
  poisonings	
  by	
  drugs	
  and	
  deaths	
  from	
  medical	
  condi;ons	
  resul;ng	
  from	
  chronic	
  drug	
  use.	
  	
  
Drug-­‐induced	
  causes	
  exclude	
  accidents,	
  homicides,	
  and	
  other	
  causes	
  indirectly	
  related	
  to	
  drug	
  use.	
  	
  Not	
  all	
  injury	
  cause	
  categories	
  are	
  mutually	
  exclusive.	
  
                               Source:	
  Na;onal	
  Center	
  for	
  Health	
  Sta;s;cs,	
  Centers	
  for	
  Disease	
  Control	
  and	
  Preven;on.	
  	
  Na;onal	
  Vital	
  Sta;s;cs	
  Reports	
  Deaths:	
  	
  Final	
  
                                         Data	
  for	
  the	
  years	
  1999	
  to	
  2009	
  (January	
  2012).	
  
Source	
  of	
  Prescrip;on	
  Pain	
  Relievers	
  




Source:	
  	
  SAMHSA,	
  Center	
  for	
  Behavioral	
  Health	
  Sta&s&cs	
  and	
  Quality,	
  Na&onal	
  
Survey	
  on	
  Drug	
  Use	
  and	
  Health,	
  2008-­‐2009	
  
Prescrip;on	
  Drug	
  Abuse	
  Preven;on	
  Plan	
  

•  Coordinated	
  effort	
  
   across	
  the	
  Federal	
  
   government	
  
•  4	
  focus	
  areas	
  
    –  Educa;on	
  
    –  Prescrip;on	
  Drug	
  
       Monitoring	
  Programs	
  
    –  Proper	
  Medica;on	
  
       Disposal	
  
    –  Enforcement	
  
Educa;on	
  
•  Educa;on	
  Goals	
  for	
  healthcare	
  providers	
  
    –  Knowledge	
  on	
  appropriate	
  prescribing	
  
    –  Effec;vely	
  iden;fying	
  those	
  at	
  risk	
  for	
  abuse	
  
    –  PDMP	
  use	
  in	
  everyday	
  clinical	
  prac;ce	
  
    –  Screening,	
  interven;on,	
  and	
  referral	
  for	
  those	
  misusing	
  or	
  abusing	
  
       prescrip;on	
  drugs	
  
•  Main	
  Ac;ons	
  
    –  Legisla;on	
  requiring	
  mandatory	
  educa;on	
  for	
  all	
  clinicians	
  who	
  
       prescribe	
  controlled	
  substances	
  
    –  Increase	
  substance	
  abuse	
  educa;on	
  in	
  health	
  profession	
  schools,	
  
       residency	
  programs,	
  and	
  con;nuing	
  educa;on	
  
    –  Work	
  with	
  the	
  American	
  College	
  of	
  Emergency	
  Physicians	
  to	
  
       develop	
  evidence-­‐based	
  clinical	
  guidelines	
  that	
  establish	
  best	
  
       prac;ces	
  for	
  opioid	
  prescribing	
  in	
  the	
  Emergency	
  Department	
  
    –  Expedi;ng	
  research	
  on	
  the	
  development	
  of	
  abuse	
  deterrent	
  
       formula;ons	
  
Top	
  10	
  prescribing	
  special&es	
  	
  
                     immediate-­‐release	
  opioids,	
  2009	
  	
  
                                             Orthopedist;	
  7.4%	
     Unspec.;	
  4.5%	
  
           Anesthesiologists;	
  
                 3.2%	
  
         Physical	
  Med	
  &	
                                                            General	
  
          Rehab;	
  2.7%	
                                                            Prac&&oners/Family	
  
                                                                                        Medicine;	
  26.7%	
  


                           Other;	
  20.2%	
  

                                                                                                      Internal	
  Medicine;	
  
                                                                                                            15.4%	
  


                                                                               Den&sts;	
  7.7%	
  



                       Emergency	
  
                      Medicine;	
  4.7%	
   Physicians	
  
                                                                                           Nurse	
  Prac&&oners;	
  
                                       Assistants;	
  4.0%	
                                         3.5%	
  


SDI, Vector One: National, 2009. Extracted June 2010.
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM217510.pdf
Top	
  10	
  prescribing	
  special&es	
  	
  
  extended-­‐release/long	
  ac&ng	
  opioids,	
  2009	
  	
  
                                                         Other;	
  11.8%	
                     General	
  
                                                                                            Prac&&oners/
                                                                                          Family	
  Medicine;	
  
                                Anesthesiologists;	
                                            27.0%	
  
                                     13.8%	
  

                       Physical	
  Med	
  &	
  
                        Rehab;	
  9.3%	
  
                                                                                                           Internal	
  Medicine;	
  
                                                                                                                 16.8%	
  




               Unspec.;	
  4.9%	
  
                      Neurologist;	
  2.8%	
  
                    Orthopedist;	
  1.9%	
                        Physicians	
  
                                                                Assistants;	
  4.3%	
            Nurse	
  Prac&&oners;	
  
                                      Hematology;	
  1.7%	
                                                5.7%	
  


SDI, Vector One: National. Years 2009. Extracted June 2010.
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM217510.pdf
Educa;on	
  Gaps	
  
             •  Physicians	
  
                          –  2000	
  survey:	
  56	
  %	
  of	
  residency	
  programs	
  required	
  substance	
  use	
  
                             disorder	
  training,	
  median	
  number	
  of	
  curricular	
  hours	
  ranged	
  from	
  3	
  to	
  
                             12	
  hours1	
  
                          –  2008	
  follow-­‐up:	
  “Although	
  the	
  educa;on	
  of	
  physicians	
  on	
  substance	
  
                             use	
  disorders	
  has	
  gained	
  increased	
  aZen;on,	
  and	
  progress	
  has	
  been	
  
                             made	
  to	
  improve	
  medical	
  school,	
  residency,	
  and	
  postresidency	
  
                             substance	
  abuse	
  educa;on	
  since	
  2000,	
  these	
  efforts	
  have	
  not	
  been	
  
                             uniformly	
  applied.”2	
  
             •  Pharmacists3	
  
                          –  67.5%	
  report	
  receiving	
  two	
  hours	
  or	
  less	
  of	
  addic;on	
  or	
  substance	
  
                             abuse	
  educa;on	
  in	
  pharmacy	
  school	
  
                          –  29.2%	
  reported	
  receiving	
  no	
  addic;on	
  educa;on	
  
                          –  Pharmacists	
  with	
  greater	
  amounts	
  of	
  addic;on-­‐specific	
  educa;on:	
  	
  
                                       •  Higher	
  likelihood	
  of	
  correctly	
  answering	
  ques;ons	
  rela;ng	
  to	
  the	
  science	
  of	
  
                                          addic;on	
  and	
  substance	
  abuse	
  counseling	
  
                                       •  Counseled	
  pa;ents	
  more	
  frequently	
  and	
  felt	
  more	
  confident	
  about	
  counseling	
  


1.	
  Isaacson	
  JH,	
  Fleming	
  M,	
  Kraus	
  M,	
  Kahn	
  R,	
  Mundt	
  M.	
  A	
  Na;onal	
  Survey	
  of	
  Training	
  in	
  Substance	
  Use	
  Disorders	
  in	
  Residency	
  Programs.	
  J	
  Stud	
  Alcohol.	
  61(6):912-­‐915.	
  2000.	
  	
  
2.	
  Polydorou	
  S,	
  Gunderson	
  EW,	
  Levin	
  FR.	
  Training	
  Physicians	
  to	
  Treat	
  Substance	
  Use	
  Disorders.	
  Curr	
  Psychiatry	
  Rep.	
  10(5):399-­‐404.	
  2008.	
  
3.	
  Lafferty	
  L.	
  Hunter	
  TS,	
  Marsh	
  WA.	
  Knowledge,	
  aktudes	
  and	
  prac;ces	
  of	
  pharmacists	
  concerning	
  prescrip;on	
  drug	
  abuse.	
  J	
  Psychoac:ve	
  Drugs.	
  2006	
  Sep:38(3):229-­‐232.	
  
Proper	
  Medica;on	
  Disposal	
  

•  Goals:	
  	
  
     –  Easily	
  accessible,	
  environmentally	
  friendly	
  method	
  of	
  
        drug	
  disposal	
  that	
  reduces	
  the	
  amount	
  of	
  prescrip;on	
  
        drugs	
  available	
  for	
  diversion	
  and	
  abuse	
  
•  Main	
  Ac;ons	
  
     –  Publish	
  and	
  implement	
  regula;ons	
  allowing	
  pa;ents	
  
        and	
  caregivers	
  to	
  easily	
  dispose	
  of	
  controlled	
  
        substance	
  medica;ons	
  
     –  Next	
  DEA	
  Take	
  Back	
  Day	
  April	
  28	
  
     –  Once	
  regula;ons	
  are	
  in	
  place,	
  partner	
  with	
  
        stakeholders	
  to	
  promote	
  proper	
  medica;on	
  disposal	
  
        programs	
  
Enforcement	
  
•  Goals:	
  
    –  Assist	
  states	
  in	
  addressing	
  “pill	
  mills”	
  and	
  doctor	
  
       shopping	
  
•  Main	
  Ac;ons	
  
    –  Provide	
  technical	
  assistance	
  to	
  states	
  on	
  model	
  
       regula;ons/laws	
  for	
  pain	
  clinics	
  
    –  Encourage	
  High-­‐Intensity	
  Drug	
  Trafficking	
  Areas	
  
       (HIDTAs)	
  to	
  work	
  on	
  prescrip;on	
  drug	
  abuse	
  issues	
  
    –  Support	
  prescrip;on	
  drug	
  abuse-­‐related	
  training	
  
       programs	
  for	
  law	
  enforcement	
  
hZp://www.whitehouse.gov/ondcp	
  

More Related Content

What's hot

Students a presentation for outreach purposes
Students   a presentation for outreach purposesStudents   a presentation for outreach purposes
Students a presentation for outreach purposesRoshan Tasgaonkar
 
Agentic Health Simplified Again
Agentic Health Simplified AgainAgentic Health Simplified Again
Agentic Health Simplified AgainDenny Brennan
 
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasRx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasOPUNITE
 
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Irma Kirtadze M.D.
 
Update on Latest Drug Trends
Update on Latest Drug TrendsUpdate on Latest Drug Trends
Update on Latest Drug Trendsjcmaxwell
 
Phisical treatments in Vitiligo - Prof. Lotti Torello, MD
Phisical treatments  in Vitiligo - Prof. Lotti Torello, MDPhisical treatments  in Vitiligo - Prof. Lotti Torello, MD
Phisical treatments in Vitiligo - Prof. Lotti Torello, MDVR Foundation
 
Improving Patient Safety Outcomes: Impact of Bar-code Technology
Improving Patient Safety Outcomes: Impact of Bar-code TechnologyImproving Patient Safety Outcomes: Impact of Bar-code Technology
Improving Patient Safety Outcomes: Impact of Bar-code Technologyhospira2010
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met AntidepressivaRobHeerdink
 
MedTech_Project01_SG06
MedTech_Project01_SG06MedTech_Project01_SG06
MedTech_Project01_SG06Marc D Roup
 
Jurnal Data P4GN 2011 - Edisi 2012 - EN
Jurnal Data P4GN 2011 - Edisi 2012 - ENJurnal Data P4GN 2011 - Edisi 2012 - EN
Jurnal Data P4GN 2011 - Edisi 2012 - ENAntiNarkoba.com
 
Kansas’ Opioid Epidemic: An Epidemic of Opioid Use Disorders
Kansas’ Opioid Epidemic: An Epidemic of Opioid Use DisordersKansas’ Opioid Epidemic: An Epidemic of Opioid Use Disorders
Kansas’ Opioid Epidemic: An Epidemic of Opioid Use DisordersFan Xiong, M.P.H.
 
Obesity
ObesityObesity
Obesityraktor
 
CDISC - Healthcare, meet the Semantic Web
CDISC - Healthcare, meet the Semantic WebCDISC - Healthcare, meet the Semantic Web
CDISC - Healthcare, meet the Semantic Webhoot72
 
Utilization of FDC in children respiratory tract infection at an outpatient s...
Utilization of FDC in children respiratory tract infection at an outpatient s...Utilization of FDC in children respiratory tract infection at an outpatient s...
Utilization of FDC in children respiratory tract infection at an outpatient s...Rajiv Ahlawat | NIPER | Mohali
 
Drug Use and Road Safety - 2015
Drug Use and Road Safety - 2015Drug Use and Road Safety - 2015
Drug Use and Road Safety - 2015EasySonho
 
Policies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_revPolicies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_revOPUNITE
 
Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...
Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...
Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...MunevarS
 
Gary Franklin
Gary FranklinGary Franklin
Gary FranklinOPUNITE
 
Right drug right_test_right_time_final_rev
Right drug right_test_right_time_final_revRight drug right_test_right_time_final_rev
Right drug right_test_right_time_final_revOPUNITE
 

What's hot (20)

Students a presentation for outreach purposes
Students   a presentation for outreach purposesStudents   a presentation for outreach purposes
Students a presentation for outreach purposes
 
Agentic Health Simplified Again
Agentic Health Simplified AgainAgentic Health Simplified Again
Agentic Health Simplified Again
 
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasRx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
 
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
 
Update on Latest Drug Trends
Update on Latest Drug TrendsUpdate on Latest Drug Trends
Update on Latest Drug Trends
 
Phisical treatments in Vitiligo - Prof. Lotti Torello, MD
Phisical treatments  in Vitiligo - Prof. Lotti Torello, MDPhisical treatments  in Vitiligo - Prof. Lotti Torello, MD
Phisical treatments in Vitiligo - Prof. Lotti Torello, MD
 
Improving Patient Safety Outcomes: Impact of Bar-code Technology
Improving Patient Safety Outcomes: Impact of Bar-code TechnologyImproving Patient Safety Outcomes: Impact of Bar-code Technology
Improving Patient Safety Outcomes: Impact of Bar-code Technology
 
Biodrug expanding
Biodrug expandingBiodrug expanding
Biodrug expanding
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
 
MedTech_Project01_SG06
MedTech_Project01_SG06MedTech_Project01_SG06
MedTech_Project01_SG06
 
Jurnal Data P4GN 2011 - Edisi 2012 - EN
Jurnal Data P4GN 2011 - Edisi 2012 - ENJurnal Data P4GN 2011 - Edisi 2012 - EN
Jurnal Data P4GN 2011 - Edisi 2012 - EN
 
Kansas’ Opioid Epidemic: An Epidemic of Opioid Use Disorders
Kansas’ Opioid Epidemic: An Epidemic of Opioid Use DisordersKansas’ Opioid Epidemic: An Epidemic of Opioid Use Disorders
Kansas’ Opioid Epidemic: An Epidemic of Opioid Use Disorders
 
Obesity
ObesityObesity
Obesity
 
CDISC - Healthcare, meet the Semantic Web
CDISC - Healthcare, meet the Semantic WebCDISC - Healthcare, meet the Semantic Web
CDISC - Healthcare, meet the Semantic Web
 
Utilization of FDC in children respiratory tract infection at an outpatient s...
Utilization of FDC in children respiratory tract infection at an outpatient s...Utilization of FDC in children respiratory tract infection at an outpatient s...
Utilization of FDC in children respiratory tract infection at an outpatient s...
 
Drug Use and Road Safety - 2015
Drug Use and Road Safety - 2015Drug Use and Road Safety - 2015
Drug Use and Road Safety - 2015
 
Policies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_revPolicies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_rev
 
Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...
Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...
Science Shaping Our World-SHOW: Deconstructing the Drug Development Process: ...
 
Gary Franklin
Gary FranklinGary Franklin
Gary Franklin
 
Right drug right_test_right_time_final_rev
Right drug right_test_right_time_final_revRight drug right_test_right_time_final_rev
Right drug right_test_right_time_final_rev
 

Viewers also liked

Mike Mayer
Mike MayerMike Mayer
Mike MayerOPUNITE
 
Peter VanPelt
Peter VanPeltPeter VanPelt
Peter VanPeltOPUNITE
 
Peggy Sapp
Peggy SappPeggy Sapp
Peggy SappOPUNITE
 
Dan Smoot
Dan SmootDan Smoot
Dan SmootOPUNITE
 
Lee-Tipping
Lee-TippingLee-Tipping
Lee-TippingOPUNITE
 
Roseline Hooks
Roseline HooksRoseline Hooks
Roseline HooksOPUNITE
 
Fred Brason
Fred BrasonFred Brason
Fred BrasonOPUNITE
 
John Niedermann
John NiedermannJohn Niedermann
John NiedermannOPUNITE
 
Phil Walls
Phil WallsPhil Walls
Phil WallsOPUNITE
 
Ryan Buzzini
Ryan BuzziniRyan Buzzini
Ryan BuzziniOPUNITE
 
Barbara Krantz
Barbara KrantzBarbara Krantz
Barbara KrantzOPUNITE
 
Kristine Bowers
Kristine BowersKristine Bowers
Kristine BowersOPUNITE
 
David Aronberg
David AronbergDavid Aronberg
David AronbergOPUNITE
 
Roger West
Roger WestRoger West
Roger WestOPUNITE
 
Lynn Webster
Lynn  WebsterLynn  Webster
Lynn WebsterOPUNITE
 
Elinore McCance Katz-b
Elinore McCance Katz-bElinore McCance Katz-b
Elinore McCance Katz-bOPUNITE
 
Henry Spiller edited
Henry Spiller editedHenry Spiller edited
Henry Spiller editedOPUNITE
 
Erin Johnson
Erin JohnsonErin Johnson
Erin JohnsonOPUNITE
 
Operation UNITE
Operation UNITEOperation UNITE
Operation UNITEOPUNITE
 
The Partnership
The PartnershipThe Partnership
The PartnershipOPUNITE
 

Viewers also liked (20)

Mike Mayer
Mike MayerMike Mayer
Mike Mayer
 
Peter VanPelt
Peter VanPeltPeter VanPelt
Peter VanPelt
 
Peggy Sapp
Peggy SappPeggy Sapp
Peggy Sapp
 
Dan Smoot
Dan SmootDan Smoot
Dan Smoot
 
Lee-Tipping
Lee-TippingLee-Tipping
Lee-Tipping
 
Roseline Hooks
Roseline HooksRoseline Hooks
Roseline Hooks
 
Fred Brason
Fred BrasonFred Brason
Fred Brason
 
John Niedermann
John NiedermannJohn Niedermann
John Niedermann
 
Phil Walls
Phil WallsPhil Walls
Phil Walls
 
Ryan Buzzini
Ryan BuzziniRyan Buzzini
Ryan Buzzini
 
Barbara Krantz
Barbara KrantzBarbara Krantz
Barbara Krantz
 
Kristine Bowers
Kristine BowersKristine Bowers
Kristine Bowers
 
David Aronberg
David AronbergDavid Aronberg
David Aronberg
 
Roger West
Roger WestRoger West
Roger West
 
Lynn Webster
Lynn  WebsterLynn  Webster
Lynn Webster
 
Elinore McCance Katz-b
Elinore McCance Katz-bElinore McCance Katz-b
Elinore McCance Katz-b
 
Henry Spiller edited
Henry Spiller editedHenry Spiller edited
Henry Spiller edited
 
Erin Johnson
Erin JohnsonErin Johnson
Erin Johnson
 
Operation UNITE
Operation UNITEOperation UNITE
Operation UNITE
 
The Partnership
The PartnershipThe Partnership
The Partnership
 

Similar to R. Gil Kerlikowske

OR PDMP Program Details 2014
OR PDMP Program Details 2014OR PDMP Program Details 2014
OR PDMP Program Details 2014Paul Coelho, MD
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.pptShirazKhokhar1
 
Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013Heidi Denton
 
Dr. Ileana Arias
Dr. Ileana AriasDr. Ileana Arias
Dr. Ileana AriasOPUNITE
 
Drug education and prevention in England
Drug education and prevention in England Drug education and prevention in England
Drug education and prevention in England Mentor
 
Realities of addiction_volkow-final
Realities of addiction_volkow-finalRealities of addiction_volkow-final
Realities of addiction_volkow-finalOPUNITE
 
Behavior youth survey summit 2010
Behavior youth survey summit 2010Behavior youth survey summit 2010
Behavior youth survey summit 2010malcolmlanham
 
Top Therapeutic Classes by Non-Discounted Spending
Top Therapeutic Classes by Non-Discounted SpendingTop Therapeutic Classes by Non-Discounted Spending
Top Therapeutic Classes by Non-Discounted SpendingIMS Health US
 
Us response thomas_frieden
Us response thomas_friedenUs response thomas_frieden
Us response thomas_friedenOPUNITE
 
Focus on long acting opioid substitution therapy.pptx
Focus on long acting opioid substitution therapy.pptxFocus on long acting opioid substitution therapy.pptx
Focus on long acting opioid substitution therapy.pptxehab elbaz
 
Open Spaces, Healthy Places
Open Spaces, Healthy PlacesOpen Spaces, Healthy Places
Open Spaces, Healthy PlacesOpenSpaceCouncil
 
Prescription Drug Abuse in the USA
Prescription Drug Abuse in the USAPrescription Drug Abuse in the USA
Prescription Drug Abuse in the USAJack Tonkin
 
Ezose Final Presentation
Ezose Final PresentationEzose Final Presentation
Ezose Final Presentationejmillennium
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized MedicineMichel Dumontier
 
Roberta Crialesi, Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...
Roberta Crialesi,  Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...Roberta Crialesi,  Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...
Roberta Crialesi, Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...Istituto nazionale di statistica
 
Tue gs volkow
Tue gs volkowTue gs volkow
Tue gs volkowOPUNITE
 
Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...
Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...
Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...epidemico
 
Best practicestobaccocontrol.trc. 10.21.11.final
Best practicestobaccocontrol.trc. 10.21.11.finalBest practicestobaccocontrol.trc. 10.21.11.final
Best practicestobaccocontrol.trc. 10.21.11.finalBrandon Williams
 
11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptxEl Viajero
 

Similar to R. Gil Kerlikowske (20)

OR PDMP Program Details 2014
OR PDMP Program Details 2014OR PDMP Program Details 2014
OR PDMP Program Details 2014
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
 
Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013
 
Dr. Ileana Arias
Dr. Ileana AriasDr. Ileana Arias
Dr. Ileana Arias
 
Drug education and prevention in England
Drug education and prevention in England Drug education and prevention in England
Drug education and prevention in England
 
Realities of addiction_volkow-final
Realities of addiction_volkow-finalRealities of addiction_volkow-final
Realities of addiction_volkow-final
 
Behavior youth survey summit 2010
Behavior youth survey summit 2010Behavior youth survey summit 2010
Behavior youth survey summit 2010
 
Top Therapeutic Classes by Non-Discounted Spending
Top Therapeutic Classes by Non-Discounted SpendingTop Therapeutic Classes by Non-Discounted Spending
Top Therapeutic Classes by Non-Discounted Spending
 
Us response thomas_frieden
Us response thomas_friedenUs response thomas_frieden
Us response thomas_frieden
 
Focus on long acting opioid substitution therapy.pptx
Focus on long acting opioid substitution therapy.pptxFocus on long acting opioid substitution therapy.pptx
Focus on long acting opioid substitution therapy.pptx
 
Open Spaces, Healthy Places
Open Spaces, Healthy PlacesOpen Spaces, Healthy Places
Open Spaces, Healthy Places
 
Prescription Drug Abuse in the USA
Prescription Drug Abuse in the USAPrescription Drug Abuse in the USA
Prescription Drug Abuse in the USA
 
Ezose Final Presentation
Ezose Final PresentationEzose Final Presentation
Ezose Final Presentation
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
 
Roberta Crialesi, Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...
Roberta Crialesi,  Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...Roberta Crialesi,  Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...
Roberta Crialesi, Alessandra Burgio, Francesco Grippo, Marilena Pappagallo -...
 
Crialesi morbosità e mortalità
Crialesi  morbosità e mortalitàCrialesi  morbosità e mortalità
Crialesi morbosità e mortalità
 
Tue gs volkow
Tue gs volkowTue gs volkow
Tue gs volkow
 
Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...
Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...
Risk of Opioid Overdose Death in North Carolina by Type of Opioid and Other C...
 
Best practicestobaccocontrol.trc. 10.21.11.final
Best practicestobaccocontrol.trc. 10.21.11.finalBest practicestobaccocontrol.trc. 10.21.11.final
Best practicestobaccocontrol.trc. 10.21.11.final
 
11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx
 

More from OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 

More from OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Recently uploaded

Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Dipal Arora
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...Dipal Arora
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...indiancallgirl4rent
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...vidya singh
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...chandars293
 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...narwatsonia7
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Haridwar Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Haridwar Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Genuine Call Girls
 
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeCall Girls Delhi
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 

Recently uploaded (20)

Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 8250192130 ⟟ Call Me For Ge...
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Haridwar Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Haridwar Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 

R. Gil Kerlikowske

  • 1.
  • 2. Preven&ng  Prescrip&on  Drug  Abuse   April  10-­‐12,  2012   Walt  Disney  World  Swan  Resort   R.  Gil  Kerlikowske,   Director   White  House  Office  of  Na;onal  Drug  Control  Policy  
  • 3. Na;onal  Drug  Control  Strategy   •  Science-­‐based,  public  health  approach  to  drug  policy   •  Coordinated  federal  effort  on  115  ac&on  items     –  Special  emphasis  on  ac&ve  duty,  veterans,  and  military  families;  women  and  girls;   individuals  in  the  criminal  jus&ce  system;  and  college  students   •  Signature  ini&a&ves   –  Prescrip&on  Drug  Abuse   –  Preven&on   –  Drugged  Driving  
  • 4. Pain  Reliever  Prescrip;ons:  2000-­‐2009   ER  –  Extended  Release,  LA  –  Long-­‐Ac&ng,  IR  –  Immediate  Release   Source:  SDI,  Vector  One:  Na;onal.    Extracted  June  2010.  
  • 5. 2011 Monitoring the Future Study   Prevalence of Past Year Drug Use Among 12th graders   Drug Prev. Drug Prev. Alcohol 63.5 OxyContin* 4.9 Marijuana/Hashish 36.4 Sedatives* 4.3 Synthetic Marijuana 11.4 Hall other than LSD 4.3 Amphetamines* 8.2 Inhalants 3.2 Vicodin* 8.1 Cocaine (any form) 2.9 Adderall* 6.5 LSD 2.7 Salvia 5.9 Ritalin* 2.6 Tranquilizers* 5.6 Ketamine 1.7 Cough Medicine* 5.3 Provigil 1.5 MDMA (Ecstasy) 5.3 GHB 1.4 Hallucinogens 5.2 Methamphetamine 1.4 * Nonmedical use Categories not mutually exclusive
  • 6. Prescrip;ons  Dispensed  for  select  opioids  in  U.S.   Outpa;ent  Retail  Pharmacies,  2000-­‐2009   140,000,000   120,000,000   100,000,000   Number  of  Prescrip;ons   80,000,000   60,000,000   40,000,000   20,000,000   0   2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   Hydrocodone   Oxyocodne   methadone   buprenorphine   tramadol   Source:  SDI,  Vector  One:  Na;onal.    Extracted  June  2010.  
  • 7. Uninten&onal  Drug  Overdose  Deaths   United  States,  1970–2007   27,658  uninten&onal  drug  overdose  deaths   Cocaine   Heroin   Year   Na;onal  Vital  Sta;s;cs  System,  hZp://wonder.cdc.gov  
  • 9. Persons  Classified  with  Substance  Abuse/ Dependence  on  Psychotherapeu;cs   2,500   2,000   1,500   1,000   500   0   2002   2003   2004   2005   2006   2007   2008   2009   2010*   Results  from  the  2010  Na2onal  Survey  on  Drug  Use  and  Health  (NSDUH):  Na2onal  Findings,  SAMHSA  (2011).     hXp://www.oas.samhsa.gov/nsduhLatest.htm.   *Number  in  2010  is  sta;s;cally  significantly  higher  than  in  2005.  
  • 10. Drug-­‐Induced  Deaths  vs.  Other  Injury  Deaths,  1999– 2009   50,000 45,000 NUMBER OF DEATHS 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0 1999   2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   Injury  by  firearms   28,874   28,663   29,573   30,242   30,136   29,569   30,694   30,896   31,224   31,593   31,347   Drug-­‐induced   19,128   19,720   21,705   26,040   28,723   30,711   33,541   38,396   38,371   38,649   39,147   Homicide   16,889   16,765   20,308   17,638   17,732   17,357   18,124   18,573   18,361   17,826   16,799   Suicide   29,199   29,350   30,622   31,655   31,484   32,439   32,637   33,300   34,598   36,035   36,909   Motor  vehicle  accidents   42,401   43,356   43,788   45,380   44,757   44,933   45,343   45,316   43,495   39,790   36,216   Causes  of  death  aZributable  to  drugs  include  accidental  or  inten;onal  poisonings  by  drugs  and  deaths  from  medical  condi;ons  resul;ng  from  chronic  drug  use.     Drug-­‐induced  causes  exclude  accidents,  homicides,  and  other  causes  indirectly  related  to  drug  use.    Not  all  injury  cause  categories  are  mutually  exclusive.   Source:  Na;onal  Center  for  Health  Sta;s;cs,  Centers  for  Disease  Control  and  Preven;on.    Na;onal  Vital  Sta;s;cs  Reports  Deaths:    Final   Data  for  the  years  1999  to  2009  (January  2012).  
  • 11. Source  of  Prescrip;on  Pain  Relievers   Source:    SAMHSA,  Center  for  Behavioral  Health  Sta&s&cs  and  Quality,  Na&onal   Survey  on  Drug  Use  and  Health,  2008-­‐2009  
  • 12. Prescrip;on  Drug  Abuse  Preven;on  Plan   •  Coordinated  effort   across  the  Federal   government   •  4  focus  areas   –  Educa;on   –  Prescrip;on  Drug   Monitoring  Programs   –  Proper  Medica;on   Disposal   –  Enforcement  
  • 13. Educa;on   •  Educa;on  Goals  for  healthcare  providers   –  Knowledge  on  appropriate  prescribing   –  Effec;vely  iden;fying  those  at  risk  for  abuse   –  PDMP  use  in  everyday  clinical  prac;ce   –  Screening,  interven;on,  and  referral  for  those  misusing  or  abusing   prescrip;on  drugs   •  Main  Ac;ons   –  Legisla;on  requiring  mandatory  educa;on  for  all  clinicians  who   prescribe  controlled  substances   –  Increase  substance  abuse  educa;on  in  health  profession  schools,   residency  programs,  and  con;nuing  educa;on   –  Work  with  the  American  College  of  Emergency  Physicians  to   develop  evidence-­‐based  clinical  guidelines  that  establish  best   prac;ces  for  opioid  prescribing  in  the  Emergency  Department   –  Expedi;ng  research  on  the  development  of  abuse  deterrent   formula;ons  
  • 14. Top  10  prescribing  special&es     immediate-­‐release  opioids,  2009     Orthopedist;  7.4%   Unspec.;  4.5%   Anesthesiologists;   3.2%   Physical  Med  &   General   Rehab;  2.7%   Prac&&oners/Family   Medicine;  26.7%   Other;  20.2%   Internal  Medicine;   15.4%   Den&sts;  7.7%   Emergency   Medicine;  4.7%   Physicians   Nurse  Prac&&oners;   Assistants;  4.0%   3.5%   SDI, Vector One: National, 2009. Extracted June 2010. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM217510.pdf
  • 15. Top  10  prescribing  special&es     extended-­‐release/long  ac&ng  opioids,  2009     Other;  11.8%   General   Prac&&oners/ Family  Medicine;   Anesthesiologists;   27.0%   13.8%   Physical  Med  &   Rehab;  9.3%   Internal  Medicine;   16.8%   Unspec.;  4.9%   Neurologist;  2.8%   Orthopedist;  1.9%   Physicians   Assistants;  4.3%   Nurse  Prac&&oners;   Hematology;  1.7%   5.7%   SDI, Vector One: National. Years 2009. Extracted June 2010. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM217510.pdf
  • 16. Educa;on  Gaps   •  Physicians   –  2000  survey:  56  %  of  residency  programs  required  substance  use   disorder  training,  median  number  of  curricular  hours  ranged  from  3  to   12  hours1   –  2008  follow-­‐up:  “Although  the  educa;on  of  physicians  on  substance   use  disorders  has  gained  increased  aZen;on,  and  progress  has  been   made  to  improve  medical  school,  residency,  and  postresidency   substance  abuse  educa;on  since  2000,  these  efforts  have  not  been   uniformly  applied.”2   •  Pharmacists3   –  67.5%  report  receiving  two  hours  or  less  of  addic;on  or  substance   abuse  educa;on  in  pharmacy  school   –  29.2%  reported  receiving  no  addic;on  educa;on   –  Pharmacists  with  greater  amounts  of  addic;on-­‐specific  educa;on:     •  Higher  likelihood  of  correctly  answering  ques;ons  rela;ng  to  the  science  of   addic;on  and  substance  abuse  counseling   •  Counseled  pa;ents  more  frequently  and  felt  more  confident  about  counseling   1.  Isaacson  JH,  Fleming  M,  Kraus  M,  Kahn  R,  Mundt  M.  A  Na;onal  Survey  of  Training  in  Substance  Use  Disorders  in  Residency  Programs.  J  Stud  Alcohol.  61(6):912-­‐915.  2000.     2.  Polydorou  S,  Gunderson  EW,  Levin  FR.  Training  Physicians  to  Treat  Substance  Use  Disorders.  Curr  Psychiatry  Rep.  10(5):399-­‐404.  2008.   3.  Lafferty  L.  Hunter  TS,  Marsh  WA.  Knowledge,  aktudes  and  prac;ces  of  pharmacists  concerning  prescrip;on  drug  abuse.  J  Psychoac:ve  Drugs.  2006  Sep:38(3):229-­‐232.  
  • 17.
  • 18. Proper  Medica;on  Disposal   •  Goals:     –  Easily  accessible,  environmentally  friendly  method  of   drug  disposal  that  reduces  the  amount  of  prescrip;on   drugs  available  for  diversion  and  abuse   •  Main  Ac;ons   –  Publish  and  implement  regula;ons  allowing  pa;ents   and  caregivers  to  easily  dispose  of  controlled   substance  medica;ons   –  Next  DEA  Take  Back  Day  April  28   –  Once  regula;ons  are  in  place,  partner  with   stakeholders  to  promote  proper  medica;on  disposal   programs  
  • 19. Enforcement   •  Goals:   –  Assist  states  in  addressing  “pill  mills”  and  doctor   shopping   •  Main  Ac;ons   –  Provide  technical  assistance  to  states  on  model   regula;ons/laws  for  pain  clinics   –  Encourage  High-­‐Intensity  Drug  Trafficking  Areas   (HIDTAs)  to  work  on  prescrip;on  drug  abuse  issues   –  Support  prescrip;on  drug  abuse-­‐related  training   programs  for  law  enforcement